| Summary: | Sm-153/Ho-166-chitosan complexes have been considered promising agents for internal radiation therapy. By direct administration, complexes solution converts into a gel, at physiological pH, allowing its retention for a long time. Herein, we report on the synthesis of Sm-153/Ho-166 complexes with the novel amino acid-chitosan polymers, N-(gamma-propanoylvalin)-chitosan (CHICO-val) and N-(gamma-propanoyl-aspartic acid)-chitosan (CHICO-asp). The main goal of this study was to obtain data on the radiochemical and biological behaviour of these complexes and information regarding their therapeutic potential when compared to Sm-153/Ho-166-chitosan. Radiolabelling yield of Sm-153/Ho-166-amino acid-chitosan complexes was dependent on polymer concentration but less dependent on pH. Radiochemical stability was shown to be higher for amino acid-chitosans than for chitosan, with Sm-153/Ho-166-CHICO-val being stable up to 3 h, while Sm-153/Ho-166-CHICO-asp is stable up to 24 h. In the presence of ascorbic acid radiochemical stability of Sm-153/Ho-166-CHICO-val and Sm-153/Ho-166-CHICO was improved, decreasing for Sm-153/Ho-166-CHICO-asp. In vivo behaviour of Sm-153 complexes was studied in mice. The radioactive amino acid-chitosans can be directly injected into blood stream without significant retention on injection site, being trapped by liver. Biodistribution studies suggest that the radioactive amino acid-chitosans, due to its water solubility and stability may be considered potential candidates to be further explored for liver targeted nuclear therapy.
|
|---|